USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Analysis of the Global Oncology Drug Delivery Market
Analysis of the Global Oncology Drug Delivery Market
Future Impact of Emerging Technologies
RELEASE DATE
24-Feb-2015
24-Feb-2015
REGION
Asia Pacific
Asia Pacific
Research Code: P874-01-00-00-00
SKU: LS00150-AP-MR_16991
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
LS00150-AP-MR_16991
Description
The global oncology drug delivery market (or oncolytics market) was worth $91.00 billion in 2013 and has been growing at an annual rate of 5.0%. The market, which includes drug delivery systems for cancer therapy and cancer pain, is expected to generate $100.96 billion in 2015. The oral drug delivery systems segment accounted for an estimated 25.0% of the total global market in 2013 and will continue to grow stronger in 2015. Currently, the injectable drug delivery system segment leads the cancer drug delivery market; however, nanoparticles (including micro-needles, patches, and orals) are expected to lead the market in the future.
RESEARCH: INFOGRAPHIC
This infographic presents a brief overview of the research, and highlights the key topics discussed in it.Click image to view it in full size
Table of Contents
Key Findings
Key Findings (continued)
Key Findings—Options in the Oncology Drug Delivery Market
Scope and Segmentation
Key Questions This Study Will Answer
Market Engineering Measurements
CEO’s Perspective
Key Technologies to Watch
3 Key Predictions
Market Background
Market Segmentation
Total Oncology Drug Delivery Market—Segmentation by Type of Delivery
Total Oncology Drug Delivery Market—Segmentation by Type of Delivery (continued)
Total Oncology Drug Delivery Market—Segmentation by Region
Total Oncology Drug Delivery Market—Segmentation by Top 5 Competitors
Cancer Pain Management Market
New Market Opportunities
Pipeline of Products in Oncology Drug Delivery Market
Attractiveness in Oncology Drug Delivery Market
Market Drivers
Drivers Explained
Drivers Explained (continued)
Market Restraints
Restraints Explained
Market Engineering Measurements
Forecast Assumptions
Revenue Forecast
Revenue Forecast by Segment
Revenue Forecast Discussion
Oral or Injectable Drug Delivery Systems—New Options for Payors
Oral or Injectable Drug Delivery Systems—New Options for Payors (continued)
Oral or Injectable Drug Delivery Systems—New Options for Payors (continued)
Oral or Injectable Drug Delivery Systems—New Options for Payors (continued)
Porter’s 5 Force Analysis
Market Engineering Measurements
Injectable Drug Delivery System Segment—Revenue Forecast
Revenue Forecast Discussion
Injectable Drug Delivery System Segment—Competitive Assessment
Market Engineering Measurements
Oral Drug Delivery System Segment
Revenue Forecast Discussion
Oral Oncolytic—Past, Present, and Future Options
Oral Drug Delivery System Segment—Competitive Assessment
US Market—Overview of Oncology Drug Delivery Market
US Oncology Drug Delivery Market—Revenue Forecast
Europe Market—Overview of Cancer Drug Delivery System
Europe Oncology Drug Delivery Market—Revenue Forecast
RoW Oncology Drug Delivery Market—Overview of Cancer Drug Delivery System
RoW Oncology Drug Delivery Market—Revenue Forecast
Nano Drug Delivery—Future of Cancer Drug Delivery Systems
Currently Marketed Nano Drug Delivery Systems—All Injectable Drug Delivery Systems
Nano Drug Delivery System—Segmentation
Attractive Nano Drug Delivery Systems
Key Nano Drug Delivery Systems—High Potential and Equally Attractive Technology for Future
Intra-nasal Drug Delivery—Next Option in Cancer Pain
Becton, Dickinson and Company (BD)
Evotec AG
Juno Therapeutics, Inc.
West Pharmaceuticals
NEONC Technologies Inc. (NTI)
Future of Cancer Drugs—Drugs in Cases where Tumour will no Longer Respond to Standard Therapy
Conclusions
Frost & Sullivan Awards
Legal Disclaimer
Market Engineering Methodology
Learn More—Next Steps
Popular Topics
The global oncology drug delivery market (or oncolytics market) was worth $91.00 billion in 2013 and has been growing at an annual rate of 5.0%. The market, which includes drug delivery systems for cancer therapy and cancer pain, is expected to generate $100.96 billion in 2015. The oral drug delivery systems segment accounted for an estimated 25.0% of the total global market in 2013 and will continue to grow stronger in 2015. Currently, the injectable drug delivery system segment leads the cancer drug delivery market; however, nanoparticles (including micro-needles, patches, and orals) are expected to lead the market in the future.
| No Index | No |
|---|---|
| Podcast | No |
| Author | Siddharth Dutta |
| WIP Number | P874-01-00-00-00 |
| Is Prebook | No |